i) Chemotherapy of tuberculosis and leprosy

Curriculum Unit: 3. Chemotherapy

This study module covers "Chemotherapy of tuberculosis and leprosy", an integral component of the Year 3 Doctor of Pharmacy (Pharm.D) curriculum under Pharmacology-II (Chemotherapy). Designed for clinical pharmacy scholars, the syllabus emphasizes mechanistic understanding, clinical relevance, and high-yield examination competencies.

Upon reviewing this syllabus topic, Pharm.D students are expected to demonstrate proficiency in:

• Understand the foundational etiology, classification, and clinical significance of Chemotherapy of tuberculosis and leprosy.
• Analyze the underlying pathophysiology and disease manifestations relevant to Chemotherapy.
• Evaluate evidence-based pharmacotherapeutic management, therapeutic drug choices, and dosage individualization.
• Identify critical patient monitoring parameters, adverse drug reactions (ADRs), and drug-drug interactions.

Standard literature and institutional sources for Pharmacology-II:

• [1]Pharmacy Council of India (PCI) Pharm.D Curriculum Syllabus Guidelines
• [2]Goodman & Gilman's: The Pharmacological Basis of Therapeutics (Brunton et al.)
• [3]Rang & Dale's Pharmacology (Humphrey P. Rang et al.)
• [4]Casarett & Doull's Toxicology: The Basic Science of Poisons